Skip to main content

Table 1 Baseline and intra-operative characteristics in patients with and without surgery-related loss of muscle quantity or quality

From: Risk factors for surgery-related muscle quantity and muscle quality loss and their impact on outcome

Factors

Total n = 128 (100%)

Muscle quantity loss n = 67 (52%)

No muscle quantity loss n = 61 (48%)

P-value

Muscle quality loss n = 83 (65%)

No muscle quality loss n = 45 (35%)

P-value

Age, mean (SD), years

65.5 (8.7)

65.4 (7.7)

65.6 (9.6)

0.896

66.9 (7.8)

62.7 (9.6)

0.008

Sex, male

89 (69.5%)

50 (74.6%)

39 (63.9%)

0.249

62 (74.7%)

27 (60.0%)

0.085

BMI, mean (SD), kg/m2

25.6 (3.1)

25.9 (3.0)

25.5 (3.2)

0.473

25.8 (3.1)

25.5 (3.1)

0.677

CEAa, median (IQR), μg/L

6.3 (2.8–22.3)

5.7 (2.4–19.0)

8.0 (3.2–33)

0.146

6.5 (2.9–35.0)

5.6 (2.6–15.0)

0.322

ASA score

 I

14 (10.9%)

7 (10.4%)

7 (11.5%)

0.580

6 (7.2%)

8 (17.8%)

0.184

 II

107 (83.6%)

55 (82.1%)

52 (85.2%)

 

72 (86.7%)

35 (77.8%)

 

 III

7 (5.5%)

5 (7.5%)

2 (3.3%)

 

5 (6.0%)

2 (4.4%)

 

Comorbidities

 Diabetes

7 (5.5%)

5 (7.5%)

2 (3.3%)

0.298

5 (6%)

2 (4.4%)

0.707

 Chronic obstructive pulmonary disease

6 (4.7%)

5 (7.5%)

1 (1.6%)

0.120

4 (4.8%)

2 (4.4%)

0.924

Charlson Comorbidity Index

 0

103 (80.5%)

53 (79.1%)

50 (82%)

0.786

66 (79.5%)

37 (82.2%)

0.867

 I

19 (14.8%)

10 (14.9%)

9 (14.8%)

 

13 (15.7%)

6 (13.3%)

 

 II

5 (3.9%)

3 (4.5%)

2 (3.2%)

 

3 (3.6%)

2 (4.4%)

 

 III

1 (0.8%)

1 (1.5%)

0 (0.0%)

 

1 (1.2%)

0 (0.0%)

 

CT scan

 Time-frame pre-scan and OK, mean (SD), days

28.2 (9.6)

28.4 (9.9)

27.9 (9.2)

0.755

27.1 (9.5)

30.1 (9.5)

0.091

 Time-frame OK and post-scan, mean (SD), days

7.1 (3.0)

7.4 (3.4)

6.6 (2.5)

0.130

6.7 (2.7)

7.6 (3.5)

0.175

Operation type

 Laparoscopic/open

15 (11,7%)/113 (88,3%)

6 (9.0%)/61 (91%)

9 (14.8%)/52 (85.2%)

0.308

4 (4,8%)/79 (95.2%)

11 (24,4%)/34 (75,6%)

0.001

 Minor/major

74 (57.8%)/54 (42.2%)

37 (55.2%)/30 (44.8%)

37 (60.7%)/24 (39.3%)

0.534

47 (56.6%)/36 (43.3%)

27 (60.0%)/18 (40%)

0.712

 Resection/resection + RFA

104 (81.3%)/24 (18.8%)

49 (73.1%)/18 (26.9%)

55 (90.2%)/6 (9.8%)

0.014

65 (78.3%)/18 (21.7%)

39 (86.7%)/6 (13.3%)

0.248

Operation parameters

 Blood loss, median (IQR), mL

400 (200–750)

400 (187–700)

400 (200–800)

0.728

500 (200–763)

300 (100–625)

0.062

 Operation time, mean (SD), min

134.2 (61.6)

130.2 (58.9)

138.8 (64.6)

0.434

142.7 (65)

118.1 (51.1)

0.035

  1. SD standard deviation, IQR interquartile range, BMI body mass index, CEA carcinoembryonic antigen, ASA American Society of Anaesthesiologists, CT computer tomography, RFA radiofrequency ablation
  2. The values given are numbers of patients unless indicated otherwise. Bold variables were considered statistically significant (P < 0.05)
  3. a28 patients missing